/Companies

Endogenex

Minneapolis, US · Founded 2017 · 28 employees on LinkedIn · 6 known investors

Find your way into Endogenex

Sign up to see every warm intro you have to Endogenex

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Endogenex team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes. Developed in partnership with Mayo Clinic, the therapy aims to help patients manage blood glucose levels and slow disease progression.

Founders & leadership

SPStacey Pugh
Stacey PughCEO
CSChris Sorli, MD, PhD
Chris Sorli, MD, PhDChief Medical Officer
KW
Krissy WrightChief Financial OfficerKrissy Wright is Chief Financial Officer at Endogenex, a clinical-stage medical device company developing a non-thermal pulsed electric field therapy for type 2 diabetes. She has spent the past two years at Endogenex and brings experience in capital strategy, multi-functional operations leadership, and scaling companies toward commercial readiness.
LC
Lian Cunningham, MD, PhDVP Clinical Affairs
MHMelanie Hess
Melanie HessRegulatory Affairs LeadershipVice President at Endogenex focused on regulatory affairs and compliance strategy. Hess brings experience in regulatory submission strategy, quality systems, and healthcare operations across multiple device classifications.
MCMatt Cambronne
Matt CambronneTechnical/Engineering Leadership
BK
Barham K. Abu DayyehCo-inventor, pulsENDO system

Investors · 6

Funding

SEC filings, press & company announcements

$50M disclosed across 1 of 3 rounds · 2024–2026

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 4

Companies working in the same space as Endogenex.

In the news

Frequently asked questions

What does Endogenex do?
Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes. Developed in partnership with Mayo Clinic, the therapy aims to help patients manage blood glucose levels and slow disease progression.
Who are Endogenex's investors?
Endogenex's investors include Arboretum Ventures, Hatteras Venture Partners, Intuitive Ventures, Longitude Capital, Lumira Ventures, Southeast Minnesota Capital Fund.
How much funding has Endogenex raised?
Endogenex has disclosed $50M raised across 1 of its 3 known rounds.
Where is Endogenex headquartered?
Endogenex is headquartered in Minneapolis, US.